Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Control Study of Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer Patients

NCT00438100 is registered in ClinicalTrials.gov with Japan Breast Cancer Research Network as lead sponsor.

NCT NCT00438100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00438100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Control Study of Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer Patients
Lead sponsor
Japan Breast Cancer Research Network
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
May 31, 2013
Enrollment
142 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms